Strong Regional Growth Expected In 2011

BMI View: Combined sales of prescription drugs and over-the-counter (OTC) medicines in Asia Pacific will increase from US$227bn in 2010 to US$245bn in 2011. Although there will be market contractions in Australia and New Zealand - primarily caused by local currency depreciation - the core regional scenario is increased demand for healthcare in general and pharmaceuticals in particular. We continue to expect Asia Pacific to be the outperforming region.

To read the full article, please choose one of the following options: